New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics

May 2016

Welcome to the May 2016 issue of PharmSource PERISCOPE

This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.

Enjoy the May issue!

The PharmSource Team

 

PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity

Lead Type April 2016 CY 2016
Early Development 100 344
Late Development 106 386
Biologic 97 321
Small Molecule 230 826
Parenteral 110 387
Oral 88 314
New Financings 67 317
Total Drug Leads 347 1377
Total Device &
Diagnostic Leads
146 549

*Total leads include acquisitions/alliances, company acquisition/alliances and events.


 

Pipeline Tip

Karus Therapeutics Ltd plans to initiate a Phase I study in Q3 of 2016 with KA2507 as a treatment for multiple myeloma:

  • Therapeutic Area: Oncology – Other
  • Dosage Form: Oral
  • API: Chemical – Normal potency

Get deeper information about the likely upcoming needs of Karus Therapeutics, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.
 

Using the PharmSource Lead Sheet for Trend Analysis

by Brooke Wilson, Senior Research Analyst

We aren’t just interested in weekly leads here at PharmSource, but in trends over months, and from year-to-year. The dashboard you land on each week when you click on your PharmSource Lead Sheet link immediately delivers you a visual depiction of weekly trends broken down in a variety of different ways, including by Development Phase, APIs, Dosage Forms and Therapeutic Areas. You can also see a breakdown of leads geographically and… read on
 

Lead Generation: Two Cardinal Rules for CRM Success

Customer Relationship Management (CRM) software should measurably improve business outcomes. When well implemented and expertly managed, it can yield significant gains in internal productivity and promote company-wide collaboration.

Data is the linchpin on which CRMs rest, and this foundation needs to be soundly built and maintained. This requires that marketing, inside sales and field sales staff all embrace data entry and upkeep religiously. A systematic approach is required to ensure that new data is both appropriate and accurate, and existing data is updated in a timely way.

Because we specialize in lead-generation, data input is the closest CRM component to our wheelhouse. There are two cardinal rules for CRM success… read on
 

Follow the Money to

Medical Device & Diagnostic Opportunities

Spotlight on Organogenesis, Inc.

Organogenesis is a private US company that focuses on regenerative medicine, specializing in bio-active wound healing, oral regeneration and bio-surgery. They raised $30 million in a completion of a venture capital investment.

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds for new product development and to support the expansion of… read on
 

Follow the Money to

Pharmaceutical Opportunities

Spotlight on Aradigm Corporation

Aradigm is a U.S. public biopharmaceutical company that develops and commercializes drugs delivered by inhalation for the treatment of severe respiratory disease. They plan to raise $23 million in a completion of a private debt placement.

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support current clinical development and regulatory submission of… read on
 

Do you know the best target opportunities for your CMO?

We do… and now you can, too.

This data-rich report, CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance-2016 Edition, identifies these 3 indicators of what’s ahead for your business:

1. Some companies and product types are more likely to use CMOs. Discover which ones make the cut.

2. NDA approvals are on the uptick – learn why that’s not all good news for you.

3. Outsourcing declines for global bio/pharma companies? Still plenty of opportunities when you know where to look.


 

PharmSource Lead Sheet

The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.

Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.

See for yourself how this resource can be a vital tool for building your brand and growing your market share.

To request a test-drive today, contact Nathaniel Celentano at nathaniel@pharmsouce.com / 1-703-383-4903, ext. 112 (ET USA).